IL104527A0 - Pharmaceutical compositions containing an angiotensin ii antagonist for treating abnormal tissue proliferation - Google Patents

Pharmaceutical compositions containing an angiotensin ii antagonist for treating abnormal tissue proliferation

Info

Publication number
IL104527A0
IL104527A0 IL104527A IL10452793A IL104527A0 IL 104527 A0 IL104527 A0 IL 104527A0 IL 104527 A IL104527 A IL 104527A IL 10452793 A IL10452793 A IL 10452793A IL 104527 A0 IL104527 A0 IL 104527A0
Authority
IL
Israel
Prior art keywords
angiotensin
antagonist
pharmaceutical compositions
compositions containing
abnormal tissue
Prior art date
Application number
IL104527A
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL104527A0 publication Critical patent/IL104527A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
IL104527A 1992-02-14 1993-01-27 Pharmaceutical compositions containing an angiotensin ii antagonist for treating abnormal tissue proliferation IL104527A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83744692A 1992-02-14 1992-02-14
US94259092A 1992-09-09 1992-09-09

Publications (1)

Publication Number Publication Date
IL104527A0 true IL104527A0 (en) 1993-05-13

Family

ID=27125938

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104527A IL104527A0 (en) 1992-02-14 1993-01-27 Pharmaceutical compositions containing an angiotensin ii antagonist for treating abnormal tissue proliferation

Country Status (5)

Country Link
EP (1) EP0625902A1 (en)
JP (1) JPH07503729A (en)
AU (1) AU3475693A (en)
IL (1) IL104527A0 (en)
WO (1) WO1993015734A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186606A1 (en) * 1994-03-29 1995-10-05 Edward B. Nelson Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
SG92610A1 (en) * 1997-10-24 2002-11-19 Univ Singapore The use of des-aspartate-angiotensin i as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
DK2160190T3 (en) * 2007-06-07 2016-01-11 Sigma Tau Ind Farmaceuti 5 BETA 14 BETA-androstane FOR USE FOR THE TREATMENT OF DISEASES CAUSED BY ORGAN FIBROSIS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812462A (en) * 1986-04-01 1989-03-14 Warner-Lambert Company 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid analogs having antihypertensive activity
AU1256692A (en) * 1991-02-06 1992-09-07 Schering Corporation Combination of an angiotensin II antagonist or renin inhibitor with a neutral endopeptidase inhibitor

Also Published As

Publication number Publication date
JPH07503729A (en) 1995-04-20
AU3475693A (en) 1993-09-03
WO1993015734A1 (en) 1993-08-19
EP0625902A1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
HUP9601419A2 (en) Synergetic pharmaceutical compositions for treating parkinson-disease
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
GB9410987D0 (en) High dosage pharmaceutical compositions
NZ333234A (en) Phosphinyl derivatives useful as naaladase inhibitors and pharmaceutical compositions thereof for treating prostate diseases
IL110421A0 (en) Pharmaceutical compositions for treating supraventricular tachyarrhythmias
ZA952046B (en) Benzimidazoles pharmaceutical compositions containing these compounds and processes for preparing them
IL109782A0 (en) Imidazole-5-position substituted angiotensin II antagonists and pharmaceutical compositions containing them
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
PL322526A1 (en) Azathiopyrin compositions for intracolic administration
AU8534291A (en) Renal-selective angiotensin ii antagonists for treatment of hypertension
EP0938901A4 (en) Medicinal compositions for treating liver diseases
IL105832A0 (en) Thio-substituted,nitrogencontaining,heterocyclic phosphonate compounds and pharmaceutical compositions containing them
ZA93529B (en) Benzimidazoles pharmaceutical compositions containing these compounds and processes for preparing them
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
IL104527A0 (en) Pharmaceutical compositions containing an angiotensin ii antagonist for treating abnormal tissue proliferation
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
HUT74745A (en) Pharmaceutical compositions containing p antagonist for treating pruritis, eye- and eyelid-acs and eye-and eyelid dysaesthesia
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
IL120005A0 (en) Pharmaceutical compositions for the treatment of the eye
IL106763A0 (en) Pharmaceutical compositions for treating cancer
IL109758A0 (en) Pharmaceutical compositions for treating ulcer
ZA931010B (en) Method of treating abnormal tissue proliferation by administering an angiotensin II antagonist
GB9412995D0 (en) Safety enhancing pharmaceutical compositions of an active indazole
EP1005340A4 (en) Retinoid antagonists for prevention of surgical adhesions
ZA93420B (en) Benzimidazoles pharmaceutical compositions containing these compounds and processes for preparing them